HSBC Holdings
INDV icon

HSBC Holdings’s Indivior Pharmaceuticals INDV Stock Holding History

HSBC Holdings’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,169
Closed -$434K – 3068
2026
Q1 		$434K Buy
+13,169
New +$435K ﹤0.01% 2282
2025
Q2 		– Sell
-15,823
Closed -$148K – 3121
2025
Q1 		$148K Sell
15,823
-1,745
-10% -$18.3K ﹤0.01% 2703
2024
Q4 		$226K Buy
17,568
+271
+2% +$2.79K ﹤0.01% 2652
2024
Q3 		$170K Sell
17,297
-57,083
-77% -$669K ﹤0.01% 2677
2024
Q2 		$1.17M Buy
74,380
+64,114
+625% +$1.16M ﹤0.01% 1614
2024
Q1 		$220K Sell
10,266
-32,689
-76% -$614K ﹤0.01% 2633
2023
Q4 		$649K Buy
+42,955
New +$763K ﹤0.01% 1942

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings's INDV Position: Q2 2026 in Review

HSBC Holdings sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 13,169 shares — an estimated $434K sold.

HSBC Holdings first reported a position in INDV in Q4 2023 and held it in 7 quarters. The position peaked at $1.17M in Q2 2024. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • HSBC Holdings reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 13,169 Indivior Pharmaceuticals shares in Q2 2026, an estimated $434K.
  • HSBC Holdings first reported a position in Indivior Pharmaceuticals in Q4 2023 and held it in 7 quarters.
  • HSBC Holdings's Indivior Pharmaceuticals position peaked at $1.17M in Q2 2024.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.